Hudson Bay Capital Management’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Hudson Bay Capital Management’s Portfolio PBLA Stock Details PBLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,800	Closed	-$175K	–	1066
2023 Q2	$175K	Buy	3,800 +3,208	+542%	+$650K	﹤0.01%	662
2023 Q1	$157K	Buy	+592	New	+$574K	﹤0.01%	658

Other funds holding PBLA

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Hudson Bay Capital Management's PBLA Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q3 2023, closing a stake of 3,800 shares — an estimated $175K sold.

Hudson Bay Capital Management first reported a position in PBLA in Q1 2023 and held it in 2 quarters. The position peaked at $175K in Q2 2023. 5 funds tracked by Wall St. Rank hold PBLA as of Q3 2023.

Hudson Bay Capital Management reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 3,800 Panbela Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $175K.
Hudson Bay Capital Management first reported a position in Panbela Therapeutics, Inc. Common Stock in Q1 2023 and held it in 2 quarters.
Hudson Bay Capital Management's Panbela Therapeutics, Inc. Common Stock position peaked at $175K in Q2 2023.
5 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.